Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment
Shao‐Ming Chiu(Kaohsiung Chang Gung Memorial Hospital), Chao‐Long Chen(Kaohsiung Chang Gung Memorial Hospital), Chao‐Hung Hung(Chang Gung University), Rong‐Nan Chien(Chang Gung Memorial Hospital), Tsung‐Hui Hu(National Sun Yat-sen University), Chun‐Yen Lin(Chang Gung University), Chih‐Lang Lin(Keelung Chang Gung Memorial Hospital), Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Yu‐Fan Cheng(Shanghai Medical College of Fudan University), Sheng‐Nan Lu(Chang Gung University), I‐Shyan Sheen(Chang Gung University), Ming‐Chao Tsai(Kaohsiung Chang Gung Memorial Hospital)
Cited by 13
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|547
Hepatogastroenterology
|Hepatogastroenterology|2012|536